These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 22235465)

  • 1. Visceral hypersensitivity in IBS: from bench to bedside.
    van Diest SA; Stanisor OI; de Jonge WJ; Boeckxstaens GE; van den Wijngaard RM
    J Pediatr Gastroenterol Nutr; 2011 Dec; 53 Suppl 2():S34-5. PubMed ID: 22235465
    [No Abstract]   [Full Text] [Related]  

  • 2. The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome.
    Klooker TK; Braak B; Koopman KE; Welting O; Wouters MM; van der Heide S; Schemann M; Bischoff SC; van den Wijngaard RM; Boeckxstaens GE
    Gut; 2010 Sep; 59(9):1213-21. PubMed ID: 20650926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of mucosal mast cells in visceral hypersensitivity in a rat model of irritable bowel syndrome.
    La JH; Kim TW; Sung TS; Kim HJ; Kim JY; Yang IS
    J Vet Sci; 2004 Dec; 5(4):319-24. PubMed ID: 15613815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome.
    Park JH; Rhee PL; Kim HS; Lee JH; Kim YH; Kim JJ; Rhee JC
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):71-8. PubMed ID: 16706815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visceral hypersensitivity in irritable bowel syndrome.
    Kanazawa M; Hongo M; Fukudo S
    J Gastroenterol Hepatol; 2011 Apr; 26 Suppl 3():119-21. PubMed ID: 21443723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic potential of ketotifen in irritable bowel syndrome (IBS) may involve changes in mast cells at sites beyond the rectum.
    O'Sullivan M
    Gut; 2011 Mar; 60(3):423; author rpely 423. PubMed ID: 20921205
    [No Abstract]   [Full Text] [Related]  

  • 7. Is visceral hypersensitivity correlated with symptom severity in children with functional gastrointestinal disorders?
    Castilloux J; Noble A; Faure C
    J Pediatr Gastroenterol Nutr; 2008 Mar; 46(3):272-8. PubMed ID: 18376243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal serotonin release, sensory neuron activation, and abdominal pain in irritable bowel syndrome.
    Cremon C; Carini G; Wang B; Vasina V; Cogliandro RF; De Giorgio R; Stanghellini V; Grundy D; Tonini M; De Ponti F; Corinaldesi R; Barbara G
    Am J Gastroenterol; 2011 Jul; 106(7):1290-8. PubMed ID: 21427712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated electro-acupuncture attenuates chronic visceral hypersensitivity and spinal cord NMDA receptor phosphorylation in a rat irritable bowel syndrome model.
    Tian SL; Wang XY; Ding GH
    Life Sci; 2008 Aug; 83(9-10):356-63. PubMed ID: 18694764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thermal and visceral hypersensitivity in irritable bowel syndrome patients with and without fibromyalgia.
    Moshiree B; Price DD; Robinson ME; Gaible R; Verne GN
    Clin J Pain; 2007 May; 23(4):323-30. PubMed ID: 17449993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Progress in role of estrogens in visceral hypersensitivity of IBS].
    Dong X; Chen SL
    Sheng Li Ke Xue Jin Zhan; 2010 Oct; 41(5):362-4. PubMed ID: 21416927
    [No Abstract]   [Full Text] [Related]  

  • 12. Abdominal pain in Irritable Bowel Syndrome: a review of putative psychological, neural and neuro-immune mechanisms.
    Elsenbruch S
    Brain Behav Immun; 2011 Mar; 25(3):386-94. PubMed ID: 21094682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidepressants in the treatment of irritable bowel syndrome and visceral pain syndromes.
    Crowell MD; Jones MP; Harris LA; Dineen TN; Schettler VA; Olden KW
    Curr Opin Investig Drugs; 2004 Jul; 5(7):736-42. PubMed ID: 15298070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visceral hypersensitivity: fact or fiction.
    Aziz Q
    Gastroenterology; 2006 Aug; 131(2):661-4. PubMed ID: 16890617
    [No Abstract]   [Full Text] [Related]  

  • 15. Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome.
    Barbara G; Wang B; Stanghellini V; de Giorgio R; Cremon C; Di Nardo G; Trevisani M; Campi B; Geppetti P; Tonini M; Bunnett NW; Grundy D; Corinaldesi R
    Gastroenterology; 2007 Jan; 132(1):26-37. PubMed ID: 17241857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visceral sensation and irritable bowel syndrome; with special reference to comparison with functional abdominal pain syndrome.
    Nozu T; Okumura T
    J Gastroenterol Hepatol; 2011 Apr; 26 Suppl 3():122-7. PubMed ID: 21443724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intestinal motility disorders and visceral hypersensitivity in irritable bowel syndrome].
    Ropert A; Bouguen G
    Gastroenterol Clin Biol; 2009 Feb; 33 Suppl 1():S35-9. PubMed ID: 19303537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-inflammatory modification of colonic afferent mechanosensitivity.
    Hughes PA; Brierley SM; Blackshaw LA
    Clin Exp Pharmacol Physiol; 2009 Oct; 36(10):1034-40. PubMed ID: 19566823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis of eight randomized, placebo-controlled, 12-week trials.
    Rahimi R; Nikfar S; Abdollahi M
    Clin Ther; 2008 May; 30(5):884-901. PubMed ID: 18555935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Visceral hypersensitivity of the large intestine mucosa in patients with irritable bowel syndrome--cause of the non-inflammatory changes in the pain syndrome].
    Zhukov NA; Sorokina EA; Akhmedov VA; Kopeĭkin SA; Pavlov AV; Tuleeva NK; Lazeeva TL; Ereshchenko KIu
    Eksp Klin Gastroenterol; 2003; (5):75-8, 195. PubMed ID: 14621617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.